Opinion

Video

Diagnostic Practices for RSV

Author(s):

Ryan Haumschild, PharmD, MS, MBA,Wanda Filer, MD, MBA

Focusing on the diagnosis of RSV, Mary Bridgeman, PharmD, BCPS, BCGP, provides clinical insights on signs and symptoms and testing practices.

Video content above is prompted by the following questions:

  • Do you diagnose RSV based on signs and symptoms alone or do you utilize additional testing?
    • How can you differentiate RSV infections from COVID-19 infections or other respiratory infections such as flu?
Related Videos
Related Content
RSV, COVID, Flu vaccines. | Image credit: angellodeco - stock.adobe.com
February 19th 2025

Nirsevimab, RSVpreF Saw High Uptake With No Preterm Risk for RSVpreF

Pearl Steinzor
High vaccine uptake shows promise for the prevention of respiratory syncytial virus (RSV) in infants.
Nursing home care | Image credit: Kzenon - stock.adobe.com
November 24th 2024

Low RSV Vaccination Rates in Nursing Homes Highlight Urgent Need for Uptake

Pearl Steinzor
Significant gaps in vaccination coverage among nursing home residents leaves vulnerable populations at risk for severe complications, report finds.
Air purifier | Image credit: Prathankarnpap - stock.adobe.com
November 22nd 2024

In-Room Air Purifiers Could Impact RSV Incidence Among Older Adults

Kennedy Ferruggia
Use of in-room air purifiers with HEPA-14 filters did not result in a significant reduction of acute respiratory infections.
RSV risk survey | Image credit: Richelle - stock.adobe.com
November 20th 2024

Community Pharmacies Hold Key Role in Protecting Older Adults From RSV

Pearl Steinzor
New research reveals gaps in respiratory syncytial virus (RSV) knowledge among older adults and emphasizes the impact community pharmacies can have at improving education and vaccine uptake.
Blood sample tube for RSV test. | Image credit: JUN LI - stock.adobe.com
November 15th 2024

RSV Vaccine Proven Effective in Reducing RSV-Related Hospitalizations

Kennedy Ferruggia
Respiratory syncytial virus (RSV) vaccination is approximately 77% to 81% effective against hospital and emergency department encounters among older adults, study finds.
RSV, COVID, Flu vaccines. | Image credit: angellodeco - stock.adobe.com
November 14th 2024

Impact of RSV on Hospitalizations in US Adults Prior to Vaccine Introduction

Pearl Steinzor
Respiratory syncytial virus (RSV) caused significant hospitalizations and severe outcomes in adults, especially those aged 75 years and older.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo